Investor
 

Mondobiotech is focused on the continuous discovery of medicinal product candidates, by redirecting already known peptides and other immuno-modulating substances for the use of treatment of rare and neglected diseases, with the aim of licensing-out them to third parties.

Download the reports here

mondoBIOTECH holding AG
Verena Baumann

Das Kloster
Mürgstrasse 18
CH-6370 Stans
Switzerland
T +41 (0)840 200 043
F +41 (0)840 200 044

2010